Peter Koelblinger

11PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Immunology not elsewhere classifiedMolecular targetsPredictive and prognostic markersEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 11, 2025
The discrepancy between managing the disease and a disease management program in systemic melanoma therapy.

Matthias Brandlmaier, Peter Koelblinger

|Jan 11, 2025
Therapeutic Approaches for Advanced Basal Cell Carcinoma: A Comprehensive Review.

Magdalena Hoellwerth, Matthias Brandlmaier, Peter Koelblinger

|Jun 26, 2024
Blistering erythema on the right shoulder.

Matthias Brandlmaier, Magdalena Hoellwerth, Demetrios Papadopoulos

|Apr 27, 2024
Adjuvant PD-1 Checkpoint Inhibition in Early Cutaneous Melanoma: Immunological Mode of Action and the Role of Ultraviolet Radiation.

Matthias Brandlmaier, Magdalena Hoellwerth, Peter Koelblinger

|Jan 11, 2024
Prognostic Value of Baseline 18F-FDG PET/CT to Predict Brain Metastasis Development in Melanoma Patients.

Forough Kalantari, Seyed Ali Mirshahvalad, Magdalena Hoellwerth

|Oct 09, 2023
Verwendung und Nutzen des Internets als Informationsquelle für Erkrankungen und Therapien in der Dermatologie: Usage and benefit of the Internet as a source of information on disease and therapy in dermatology.

Katja Grossschaedl, Christina Vallant, Marie-Therese Dernoscheg

Pageof 2

Frequent Collaborators

4 joint publications

Matthias Brandlmaier

3 joint publications

Roland Lang

3 joint publications

Magdalena Hoellwerth

2 joint publications

Andrea Harrer